ALLTEST Tramadol Urine Drug Test Strips Exp Date 06/26

Tramadol (TML) Rapid Urine Test Dipstick for Prescription Painkiller Screening

The TML Rapid Test Dipstick (Urine) is a professional, in vitro diagnostic screening assay designed for the rapid detection of Tramadol, a commonly prescribed opioid-like painkiller, in human urine. Tramadol is widely used in the management of moderate to severe pain, making accurate screening essential in pain management clinics, prescription drug monitoring programs, rehabilitation centers, and workplace testing.

This test delivers fast, reliable results at a 100 ng/mL cutoff, supporting the detection of prescription painkiller use, misuse, or non-compliance.

Why Test for Prescription Painkillers?

Prescription painkillers such as Tramadol, hydrocodone, oxycodone, morphine, and codeine are frequently prescribed for chronic and acute pain. However, misuse and dependency risks require ongoing monitoring. Urine drug testing plays a critical role in:

• Pain management compliance monitoring
• Prescription drug abuse screening
• Opioid stewardship programs
• Clinical and outpatient treatment settings
• Workplace drug testing involving prescribed opioids

The TML Rapid Test Dipstick specifically targets Tramadol, a synthetic opioid analgesic often excluded from standard opioid panels.

Test Principle (Prescription Painkiller Detection)

This assay uses a competitive immunochromatographic method with monoclonal antibodies specific to Tramadol and its primary metabolites. When Tramadol is present at or above the cutoff level, it prevents formation of the test line, indicating a positive result for a prescription painkiller.

• Positive: Prescription painkiller detected (Tramadol ≥100 ng/mL)
• Negative: No detectable Tramadol below cutoff
• Results available in 5 minutes

Analytical Performance for Prescription Painkiller Screening

Cutoff Level

• Tramadol (TML): 100 ng/mL

Analytical Sensitivity

Urine specimens spiked with Tramadol showed:

• ≥99% positive detection at ≥125 ng/mL
• ~50% detection at the cutoff (100 ng/mL)
• Designed to minimise false positives from sub-therapeutic levels

This ensures reliable detection of therapeutic and non-therapeutic prescription painkiller use.

Analytical Specificity

The test demonstrates high specificity for Tramadol and its active metabolites, including:

• O-Desmethyl-Tramadol
• Cis-Tramadol
• O-Desmethyl-cis-Tramadol

Extensive cross-reactivity testing showed no false positives with other prescription or over-the-counter medications, including:

• Hydrocodone
• Oxycodone
• Morphine
• Codeine
• Fentanyl
• Benzodiazepines
• NSAIDs and common analgesics

This confirms excellent analytical specificity for Tramadol-based prescription painkillers.

Clinical & Commercial Applications

• Pain management clinics
• Prescription compliance monitoring
• Opioid therapy oversight
• Rehabilitation and substance use treatment
• Workplace drug screening programs
• Forensic and laboratory screening

Important Use Information

• Provides qualitative screening results only
• Positive results should be confirmed by GC/MS or LC-MS/MS
• Not intended for self-testing
• For professional use only